Skip to main content
ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.640
+0.050 (3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.650
+0.010 (0.61%)
Pre-market: Apr 29, 2026, 8:05 AM EDT

ALX Oncology Holdings Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
220.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Heron Therapeutics 154.90M
Voyager Therapeutics 40.37M
Orchestra BioMed Holdings 33.48M
MediWound 16.96M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Artiva Biotherapeutics 251.00K
Revenue Rankings

ALXO News

More News